1-2 of 2
Leonardo Flenghi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chemoimmunotherapy with R-CHOP or High Dose Sequential Therapy with Autologous Stem Cell Transplantation (R-HDS) for High Risk Diffuse Large B-Cell Lymphomas Patients: Results of the Randomized R-HDS0305 Trial by Gruppo Italiano Terapie Innovative Nei Linfomi (GITIL)

Sergio Cortelazzo, MD, Corrado Tarella, MD, Alessandro Massimo Gianni, MD, Tiziano Barbui, MD, Marco Ladetto, MD, Anna Maria Barbui, MD, Andrea Rossi, MD, Paolo Corradini, MD, Massimo Di Nicola, MD, Caterina Patti, MD, Antonino Mulé, MD, Manuela Zanni, MD, Valerio Zoli, MD, Atto Billio, MD, Andrea Gallamini, MD, Francesco Di Raimondo, MD, Andrés J.M. Ferreri, MD, Giovanni Pizzolo, MD, Giorgio La Nasa, MD, Pietro Leoni, MD, Giampietro Semenzato, MD, Maurizio Frezzato, MD, Leonardo Flenghi, MD, Marco Scarano, Sc.D., Arianna Masciulli, BSc, Roberto Marchioli, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2012) 120 (21): 746.
https://doi.org/10.1182/blood.V120.21.746.746
Published: 2012
Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) from Alternative Donors for Acute Leukemia at High-Risk of Relapse. The Haploidentical Option.

Franco Aversa, MD, Antonio Tabilio, MD, Adelmo Terenzi, MD, Stelvio Ballanti, MD, Alessandra Carotti, MD, Franca Falzetti, MD, Andrea Velardi, MD, Teresa Aloisi, MD, Leonardo Flenghi, MD, Jean Pierre Saab, MD, Yair M. Reisner, PhD, Massimo F. Martelli, MD
Journal: Blood
Blood (2005) 106 (11): 441.
https://doi.org/10.1182/blood.V106.11.441.441
Published: 2005